At yesterday’s meeting, CT’s Health Care Cabinet agreed to create four working groups to develop recommendations and options to control drug spending in the state. We also reviewed a report from CT’s APCD on the Top 50 Highest Total Cost Drugs in CT. The Cabinet has been taking a deep dive into rising prescription drug costs for the last three months with presentations from academics, drug company and industry representatives, DSS, CT’s Attorney General, a Pharmacy Benefits Management company, wholesale drug distribution, and pharmacists. The Cabinet considered a draft summary document on the Cabinet’s activities to date, updates on legislative proposals, further reading, and potential themes and areas for further action. The group decided to create four working groups to develop strategies – pricing, price transparency, research initiatives in other states, and consumer/provider education. The subgroups will engage voices beyond the Cabinet’s membership.